QQ客服 官方微博 反馈留言

	Survival with docetaxel plus capecitabine comparing with vinorelbine plus capecitabine followed by capecitabine maintenance treatment as first-line therapy in patients with advanced breast cancer: A phase III randomized clinical trial
	Xu, Binghe; Wang, Jiayu; Li, Qing; Zhang, Pin; Yuan, Peng; Ma, Fei; Cai, Ruigang; Fan, Ying; Luo, Yang; Li, Qiao
	2014
卷号	32期号:15
ISSN号	0732-183X
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6667415
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Xu, Binghe,Wang, Jiayu,Li, Qing,et al. Survival with docetaxel plus capecitabine comparing with vinorelbine plus capecitabine followed by capecitabine maintenance treatment as first-line therapy in patients with advanced breast cancer: A phase III randomized clinical trial[J],2014,32(15).
APA	Xu, Binghe.,Wang, Jiayu.,Li, Qing.,Zhang, Pin.,Yuan, Peng.,...&Li, Qiao.(2014).Survival with docetaxel plus capecitabine comparing with vinorelbine plus capecitabine followed by capecitabine maintenance treatment as first-line therapy in patients with advanced breast cancer: A phase III randomized clinical trial.,32(15).
MLA	Xu, Binghe,et al."Survival with docetaxel plus capecitabine comparing with vinorelbine plus capecitabine followed by capecitabine maintenance treatment as first-line therapy in patients with advanced breast cancer: A phase III randomized clinical trial".32.15(2014).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。